3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
2
Thyroid Neoplasms
1
Psoriasis Vulgaris
1
Pelvic Neoplasms
1
Mucositis
1
Malnutrition
1
Infections
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Enteritis
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Cancer Therapy-related Cardiovascular Toxicity
1
Anus Neoplasms
1
Adenomatous Polyposis Coli
1
Interventions
Fluorouracil
5
Paclitaxel
3
Mitomycin
3
Capecitabine
3
fludarabine
2
Radiotherapy
2
Radiation
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
niraparib
1
dehydroftorafur
1
avelumab
1
Taxes
1
Ritonavir
1
Probiotics
1
Prebiotics
1
Platinum
1
Oxaliplatin
1
Mitomycins
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Interleukin-2
1
Indinavir
1
Immune Checkpoint Inhibitors
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Diathermy
1
Chemoradiotherapy
1
Cetuximab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Anus Neoplasms
×
Probiotics
×
Clear all
NCT03870607
2023-01-17
BISQUIT
AC Camargo Cancer Center
Phase 2
Unknown
75 enrolled